Related Experiment Video
Updated: Jul 19, 2026
06:31
Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Telemedicine evaluation of cutaneous diseases: a blinded comparative study
J L Lesher1, L S Davis, F W Gourdin
1Department of Medicine, Medical College of Georgia, Augusta 30912-3190, USA.
Journal of the American Academy of Dermatology
|February 3, 1998
Summary
Telemedicine effectively diagnoses skin conditions, though on-site evaluations show higher diagnostic agreement. Optimizing remote site support is key for improving telemedicine accuracy in dermatology.
Area of Science:
- Dermatology
- Medical Informatics
- Telehealth
Background:
- Limited studies document the effectiveness of telemedicine for diagnosing skin diseases.
- Numerous telemedicine programs exist in the United States, but their diagnostic fidelity is under-researched.
Purpose of the Study:
- To determine the diagnostic agreement between dermatologists using telemedicine versus on-site evaluations.
- To assess the reliability of telemedicine in diagnosing cutaneous conditions.
Main Methods:
- A study involving 60 patients with skin conditions was conducted using two telemedicine sites.
- Dermatologists independently diagnosed patients via telemedicine and in-person, with diagnoses compared to a control group.
- A third dermatologist classified diagnostic agreement into complete, partial, or disagreement categories.
Main Results:
- No significant differences in diagnostic disagreement were observed between telemedicine and on-site evaluations.
- Higher complete diagnostic agreement occurred when both dermatologists examined patients in person compared to telemedicine evaluations.
- Partial interobserver agreement was greater in the telemedicine group (p < 0.05).
Conclusions:
- Telemedicine is a viable method for diagnosing skin diseases.
- Enhancing the role of medical assistants at remote sites may improve diagnostic agreement in telemedicine dermatology.
- Further research into optimizing telemedicine protocols for dermatology is warranted.
Related Concept Videos
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.